Sexual Dysfunction After Menopause: Guidelines for Assessment and Management.
Dyspareunia
Female sexual dysfunction
Hormone therapy
Menopause
Journal
Obstetrics and gynecology clinics of North America
ISSN: 1558-0474
Titre abrégé: Obstet Gynecol Clin North Am
Pays: United States
ID NLM: 8709551
Informations de publication
Date de publication:
Jun 2024
Jun 2024
Historique:
medline:
23
5
2024
pubmed:
23
5
2024
entrez:
22
5
2024
Statut:
ppublish
Résumé
Female sexual dysfunction commonly occurs during the menopause transition and post-menopause due to hormonal, physiologic, and psychosocial factors. Sexuality is important to aging women; however, many are reluctant to seek treatment for their sexual concerns. Clinicians should be adept at managing and treating sexual dysfunction in this population. A multi-dimensional treatment approach that addresses modifiable mental, physical, and psychosocial factors is warranted to improve sexual function and quality of life.
Identifiants
pubmed: 38777488
pii: S0889-8545(24)00008-1
doi: 10.1016/j.ogc.2024.02.007
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
341-364Informations de copyright
Copyright © 2024 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure Dr M. Christmas reports Fertility IQ speaker honorarium, Alliance Chicago speaker honorarium, FDA Bone Reproductive and Urologic Division (BRUDAC) Committee, and wrote White Paper entitled “Genitourinary Syndrome of Menopause and Vaginismus for Materna (no payment).” Dr S. Reed reports research funding from National Institutes of Health, United States, Royalties from UpToDate, and research funding from Bayer AG, Germany.